Clene Inc. (NASDAQ: CLNN)
$4.94
-0.0600 ( -1.20% ) 33.7K
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Market Data
Open
$4.94
Previous close
$5.00
Volume
33.7K
Market cap
$31.53M
Day range
$4.90 - $5.06
52 week range
$4.59 - $17.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
3 | Insider transactions | 1 | Sep 19, 2023 |
3 | Insider transactions | 1 | Sep 19, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
8-k | 8K-related | 53 | Aug 29, 2023 |